What could a new disease activity score for polymyalgia rheumatica do better?

被引：0
|
作者：
Burkhard F. Leeb
机构：
[1] University Clinic for Internal Medicine - Rheumatology,
[2] Karl Landsteiner Institute for Clinical Rheumatology,undefined
来源：
Nature Reviews Rheumatology | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 185
相关论文
共 50 条
  • [41] DISEASE ACTIVITY, QUALITY OF LIFE AND ADVERSE EVENTS IN THE FIRST TWO YEARS OF POLYMYALGIA RHEUMATICA
    Dasgupta, B.
    Hutchings, A.
    Hollywood, J.
    Lamping, D.
    Gendi, N.
    Chakravarty, K.
    Scott, D. G.
    Bourke, B.
    Choy, E.
    Silverman, B.
    Pease, C.
    RHEUMATOLOGY, 2009, 48 : I17 - I17
  • [42] A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity
    Brun, JG
    Madland, TM
    Gran, JT
    Myklebust, G
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (02) : 125 - 128
  • [43] POLYMYALGIA RHEUMATICA - ASSESSMENT OF DISEASE ACTIVITY USING ERYTHROCYTE SEDIMENTATION-RATE AND PLASMA VISCOSITY
    ESSELINCKX, W
    BUCKNALL, RC
    DIXON, ASJ
    ANNALS OF THE RHEUMATIC DISEASES, 1977, 36 (06) : 560 - 562
  • [44] What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
    Jake Weddell
    Samantha L. Hider
    Christian D. Mallen
    Sara Muller
    Rheumatology International, 2022, 42 : 285 - 290
  • [45] What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
    Weddell, Jake
    Hider, Samantha L.
    Mallen, Christian D.
    Muller, Sara
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (02) : 285 - 290
  • [46] Effect of Tocilizumab on Disease Activity in Patients with Active Polymyalgia Rheumatica on Glucocorticoid Therapy: A Randomized Clinical Trial
    Devauchelle, Valerie
    Alegria, Guillermo Carvajal
    Dernis, Emmanuelle
    Richez, Christophe
    Truchetet, Marie
    Wendling, Daniel
    Toussirot, Eric
    Perdriger, Aleth
    Gottenberg, Jacques-Eric
    Felten, Renaud
    Fautrel, Bruno
    Chiche, Laurent
    Hilliquin, Pascal
    Le Henaff, Catherine
    Dervieux, Benjamin
    Direz, Guillaume
    Chary-Valckenaere, Isabelle
    Cornec, Divi
    Guellec, Dewi
    Marhadour, Thierry
    Nowak, Emmanule
    Saraux, Alain
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2196 - 2198
  • [47] Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica
    Jung, Ju-Yang
    Lee, Eunyoung
    Suh, Chang-Hee
    Kim, Hyoun-Ah
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (09)
  • [48] FIBRIN(OGEN)OLYSIS IN POLYMYALGIA RHEUMATICA AND TEMPORAL ARTERITIS - PRELIMINARY FINDINGS ON ASSOCIATION WITH DISEASE-ACTIVITY
    GRAU, RG
    KASSAN, SS
    FRANKS, JJ
    KAPLAN, H
    WALKER, SH
    TAN, EM
    ANNALS OF THE RHEUMATIC DISEASES, 1984, 43 (05) : 721 - 724
  • [49] NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO ARE ASSOCIATED WITH DISEASE ACTIVITY IN POLYMYALGIA RHEUMATICA
    Jung, Ju-Yang
    Kim, Jiwon
    Suh, Chang-Hee
    Kim, Hyoun-Ah
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2123 - 2123
  • [50] Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: A study of 243 scenarios
    Binard, Aymeric
    De Bandt, Michel
    Berthelot, Jean-Marie
    Saraux, Alain
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (03): : 481 - 486
12345